Fredun Pharmaceuticals Limited is a diversified healthcare company with a strong foothold in over 52 international markets, producing branded generics, nutraceuticals, cosmeceuticals, and more.

The company is expanding its state-of-the-art manufacturing facility, which supports scalability and meets growing demand, showcasing operational efficiency and strategic growth focus.

With the acquisition of One Pet Stop and Wagr.ai, Fredun enters the pet tech and grooming space, integrating technology into pet care, fostering a connected pet wellness ecosystem.

Fredun's revenues have seen a significant rise with Q2 FY '26 results showing a year-on-year income growth of 35%, and net profit growth of 128% driven by new-age verticals like nutraceutical and pet wellness.

The company owns India's only patent for bone grafts, emphasizing its dedication to healthcare innovation and differentiated product offerings.